Many healthcare professionals today (such as doctors, nurses, and dieticians) still think that it’s too much of a hassle to operate a medical weight loss program, and that there’s no profit in it. This thinking is simply not accurate, and this article will present some facts to dispel the most common myths.

A new report from The Business Research Company, shows that the global market for telemedicine technology, currently worth $31.8 billion, will reach $77.2 billion by 2022. Expansion at that rate provides great opportunities for companies and investors in the telemedicine market.

Growth in the pet population, increasing penetration of pet insurance, pet humanization within the growing global urban population and increased awareness of animal welfare needs due to social media are helping the veterinary industry to maintain growth at 6.2% a year, according to a new market research report.

Health coaching has emerged as a $6 billion service market, with a strong growth outlook. There are an estimated 109,000 health coaches and health educators that advise and motivate clients to change bad lifestyle habits and to manage chronic conditions such as diabetes.

Obesity levels in American are a significant concern, as 70% of adults are overweight or obese, with no improvement in sight. Medical conditions such as diabetes, pre-diabetes, high cholesterol, and sleep apnea are directly related to this obesity.

Although we still do not know the specific causes of autism, we do know one thing. The rate is increasing, and the market for treatment is growing.

Based on new government data, 1 in 45 children in the United States, aged 3-17, have autism. This is up from only 1 in 150 children back in 2000.

According to a new market research report by BIS Research, the global surgical robotics market is expected to reach a value of $12.6 billion by the year 2025, owing to factors such as:

According to a market research report by BIS Research titled "Global Precision Medicine Market – Analysis and Forecast (2017-2026)," the global precision medicine market is expected to reach a value of $141.7 billion by the year 2026, wherein the oncology market segment is expected to grow at a compound annual growth rate (CAGR) of 10.4% from 2017 to 2026.

Orphan disease, by definition, is “any disease that affects a small percentage of the general population.” These diseases are often life-threatening, chronic, progressive, degenerative, and disabling, while most of them are linked to a genetic disorder and remain undiagnosed.

The U.S. weight loss market is estimated to be worth $68.2 billion in 2017—a 2.7% gain, and growth should continue into 2018, when the market is expected to post a better gain of 3.2% to $70 billion.

Continued high rates of obesity and overweight, coupled with low unemployment and higher disposable income, are boosting the market. However, performance will vary significantly by individual market segment.